Back
Astrana Health 10K Form
Sell
18
ASTH
Astrana Health
Last Price:
42.9200
Seasonality Move:
23.17%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ASTH News And Ratings
See the #1 stock for the next 7 days that we like better than ASTH
ASTH Financial Statistics
Sales & Book Value
| Annual Sales: | $1.39B |
|---|---|
| Cash Flow: | $20.35M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $14.75 |
| Price / Book: | 3.17 |
Profitability
| EPS (TTM): | 1.30000 |
|---|---|
| Net Income (TTM): | $62.46M |
| Gross Margin: | $214.96M |
| Return on Equity: | 12.67% |
| Return on Assets: | 5.41% |
Astrana Health Earnings Forecast
Key Astrana Health Financial Ratios
- The Gross Profit Margin over the past 15 years for ASTH is 15.50%.
- The Selling, General & Administrative Expenses for ASTH have been equal to 8.12% of Gross Profit Margin.
- The Interest Expense is 26.52% of Operating Income.
- The Net Earning history of ASTH is 4.38% of Total Revenues.
- Per Share Earnings over the last 20 years have been positive in 8 years.
Astrana Health Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Providers & Services |
| Sector: | Health Care |
| Current Symbol: | ASTH |
| Website: | astranahealth.com |
Debt
| Debt-to-Equity Ratio: | 0.62 |
|---|---|
| Current Ratio: | 1.91 |
| Quick Ratio: | 1.84 |
Price-to-Earnings
| Trailing P/E Ratio: | 36.29 |
|---|---|
| Forward P/E Ratio: | 23.41 |
ASTH Technical Analysis vs Fundamental Analysis
Sell
18
Astrana Health (ASTH)
is a Sell
Is Astrana Health a Buy or a Sell?
-
Astrana Health stock is rated a Sell
The current Astrana Health [ASTH] share price is $46.8100. The Score for ASTH is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.